亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Tigecycline-Containing Regimens and Multi Drug-Resistant Acinetobacter baumannii: A Systematic Review and Meta-Analysis

替加环素 医学 内科学 鲍曼不动杆菌 荟萃分析 观察研究 置信区间 不动杆菌 系统回顾 梅德林 抗生素 微生物学 生物 铜绿假单胞菌 遗传学 细菌 生物化学
作者
Fatemeh Sodeifian,Moein Zangiabadian,Erfan Arabpour,Naghmeh Kian,Fartous Yazarlou,Mehdi Goudarzi,Rosella Centis,Zahra Sadat Seghatoleslami,Mahdis Chahar Kameh,Bardia Danaei,Hossein Goudarzi,Mohammad Javad Nasiri,Giovanni Sotgiu,Giovanni Battista Migliori
出处
期刊:Microbial Drug Resistance [Mary Ann Liebert, Inc.]
卷期号:29 (8): 344-359 被引量:7
标识
DOI:10.1089/mdr.2022.0248
摘要

Introduction: The use of tigecycline (TG) for the treatment of Acinetobacter baumannii is controversial. In this systematic review and meta-analysis, we aimed to better explore the safety and efficacy of TG for the treatment of multi drug-resistant (MDR) Acinetobacter. Methods: We searched PubMed/MEDLINE, Scopus, Cochrane Central, and Web of Science to identify studies reporting the clinical and microbiological efficacy and safety of regimens containing TG in patients with drug susceptibility testing (DST)-confirmed MDR A. baumannii, published until December 30, 2022. Observational studies were included if they reported clinical and microbiological efficacy of TG-based regimens. The Newcastle-Ottawa Scale (NOS) and Joana Briggs Institute (JBI) critical appraisal tool were used to assess the quality of included studies. Results: There were 30 observational studies, of which 19 studies were cohort and 11 studies were single group studies. Pooled clinical response and failure rates in the TG-containing regimens group were 58.1 (95% confidence interval [CI] 49.2-66.6) and 40.2 (95% CI 31.1-50.0), respectively. The pooled microbiological response rate was 32.1 (95% CI 19.8-47.5), and the pooled all-cause mortality rate was 41.1 (95% CI 34.1-48.4). Pooled clinical response and failure rates in the colistin-based regimens group were 52.7 (42.7-62.5) and 43.1 (33.1-53.8), respectively. The pooled microbiological response rate was 42.9 (16.2-74.5), and the pooled all-cause mortality rate was 34.3 (26.1-43.5). Conclusions: According to our results, the efficacy of the TG-based regimen is the same as other antibiotics. However, our study showed a high mortality rate and a lower rate of microbiological eradication for TG compared with colistin-based regimen. Therefore, our study does not recommend it for the treatment of MDR A. baumannii. However, this was a prevalence meta-analysis of observational studies, and for better conclusion experimental studies are required.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
怂怂鼠完成签到,获得积分10
15秒前
40秒前
负责的元柏完成签到,获得积分10
50秒前
1分钟前
段皖顺完成签到 ,获得积分10
1分钟前
1分钟前
llllll完成签到,获得积分10
1分钟前
可乐发布了新的文献求助10
1分钟前
1分钟前
lalala完成签到,获得积分10
1分钟前
1分钟前
Ancly发布了新的文献求助10
1分钟前
1分钟前
汪汪路应助奇迹探索者采纳,获得10
1分钟前
奇迹探索者完成签到,获得积分10
1分钟前
Ancly完成签到,获得积分10
1分钟前
1分钟前
ccc2完成签到,获得积分0
1分钟前
慕青应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
简单小土豆完成签到 ,获得积分10
2分钟前
Hyp完成签到 ,获得积分10
2分钟前
左左曦完成签到,获得积分10
2分钟前
liuhao完成签到,获得积分20
2分钟前
活泼的远航完成签到,获得积分10
2分钟前
Kevin完成签到 ,获得积分10
2分钟前
jumbaumba发布了新的文献求助10
2分钟前
3分钟前
3分钟前
bilin完成签到 ,获得积分10
3分钟前
jumbaumba完成签到,获得积分10
3分钟前
乐观从凝发布了新的文献求助30
3分钟前
3分钟前
咩咩发布了新的文献求助10
3分钟前
桐桐应助Sapphire采纳,获得10
3分钟前
乐观从凝关注了科研通微信公众号
3分钟前
可可完成签到,获得积分10
3分钟前
咩咩完成签到,获得积分10
3分钟前
Anlocia完成签到 ,获得积分10
4分钟前
CodeCraft应助科研通管家采纳,获得10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Quality by Design - An Indispensable Approach to Accelerate Biopharmaceutical Product Development 800
Pulse width control of a 3-phase inverter with non sinusoidal phase voltages 777
Signals, Systems, and Signal Processing 610
Research Methods for Applied Linguistics: A Practical Guide 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6399242
求助须知:如何正确求助?哪些是违规求助? 8214863
关于积分的说明 17407472
捐赠科研通 5452540
什么是DOI,文献DOI怎么找? 2881804
邀请新用户注册赠送积分活动 1858274
关于科研通互助平台的介绍 1700271